- Home
- IOR vs ATRA Comparison
IOR vs ATRA Comparison
Compare IOR & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOR
- ATRA
- Stock Information
- Founded
- IOR 1984
- ATRA 2012
- Country
- IOR United States
- ATRA United States
- Employees
- IOR N/A
- ATRA N/A
- Industry
- IOR Real Estate Investment Trusts
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IOR Real Estate
- ATRA Health Care
- Exchange
- IOR Nasdaq
- ATRA Nasdaq
- Market Cap
- IOR 72.8M
- ATRA 67.9M
- IPO Year
- IOR N/A
- ATRA 2014
- Fundamental
- Price
- IOR $17.91
- ATRA $12.12
- Analyst Decision
- IOR
- ATRA Strong Buy
- Analyst Count
- IOR 0
- ATRA 3
- Target Price
- IOR N/A
- ATRA $21.00
- AVG Volume (30 Days)
- IOR 218.0
- ATRA 57.1K
- Earning Date
- IOR 11-06-2025
- ATRA 11-11-2025
- Dividend Yield
- IOR N/A
- ATRA N/A
- EPS Growth
- IOR N/A
- ATRA N/A
- EPS
- IOR 1.06
- ATRA 0.56
- Revenue
- IOR N/A
- ATRA $188,667,000.00
- Revenue This Year
- IOR N/A
- ATRA N/A
- Revenue Next Year
- IOR N/A
- ATRA N/A
- P/E Ratio
- IOR $17.05
- ATRA $21.52
- Revenue Growth
- IOR N/A
- ATRA 202.41
- 52 Week Low
- IOR $16.01
- ATRA $5.01
- 52 Week High
- IOR $19.69
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- IOR 21.06
- ATRA 52.72
- Support Level
- IOR $17.90
- ATRA $11.70
- Resistance Level
- IOR $18.89
- ATRA $13.20
- Average True Range (ATR)
- IOR 0.02
- ATRA 0.63
- MACD
- IOR -0.03
- ATRA -0.11
- Stochastic Oscillator
- IOR 3.33
- ATRA 28.00
About IOR Income Opportunity Realty Investors Inc.
Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. The business of the company is managed by Pillar Income Asset Management, Inc. The company's activities include locating, evaluating and recommending investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).